Virus-specific T-lymphocyte responses are usually restricted by recognition of viral antigens in the context of the major histocompatibility complex (MHC) antigens (31) . Such cells can have cytolytic or helper/inducer activities. MHC class I-restricted cytolytic cells have been shown to be involved in the clearance of acute or persistent viral infections in mice (14, 16) . Generally, cytolysis by CD4+ or CD8+ T cells is mediated by cells which recognize viral antigens in association with class II or class I MHC antigens, respectively (2, 4, 6, 13, 24, 25, 27) , although a few exceptions have been reported (12, 23) . The lytic event is initiated by activation of the mechanisms of cytolysis via T-cell-receptor recognition of the viral antigens and MHC proteins. It has recently been demonstrated by Schwimmbeck et al. (22) and Tishon et al. (29) , however, that lymphocytic choriomeningitis virus can become associated with lymphocytes without T-cell-receptor-mediated binding and can be recovered from CD4+ cells by cocultivating them with permissive cells. The significance of these observations in terms of viral pathogenesis is not clear.
Vesicular stomatitis virus (VSV) specifically kills activated T cells (8) . We and others have noted that the simultaneous addition of live VSV in vitro will eliminate a virus-specific or allogeneic mixed-lymphocyte culture by killing the activated T cell. This finding is paradoxical since T cells are necessary for providing help to B cells in producing the antibodies and engaging in cytolytic and delayed-type hypersensitivity responses to the virus. If normal activated T cells were killed by live virus, there could never be a virus-specific response. This is not unlike the situation seen in humans with human immunodeficiency virus (HIV) infections in which, despite the presence of a virus which kills helper T cells, some CD4+ cells must survive infection at least long enough to help produce antibodies to HIV.
In this work, we have investigated the question of what T cells might survive VSV infection by repeated in vitro stimulation with live VSV and have characterized the surviving clone. We report a murine CD4+ CD8-VSV-specific T-cell clone which is cytolytic to VSV-infected tumor target cells which express class II (26) . Cells (3 x 106 to 5 x 106) were suspended in 1 ml of PBS containing 5 mM glucose. lodination was effected by the successive addition of Na125I (1 mCi/ml) (New England Nuclear), lactoperoxidase (20 ,ug/ml), and glucose oxidase (0.65 units/ml) (Sigma). The reaction mixture was incubated at 20°C for 20 min with swirling. The cells were washed twice in PBS and then lysed in buffer containing 10 mM Tris hydrochloride (pH 7.4), 0.15 M NaCl, 2 mM EDTA, 2 mM ethylene glycol-bis(P-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA), 20 IU of aprotinin per ml, 1% Triton, and 1 mM freshly prepared phenylmethylsulfonyl fluoride (Sigma). After 1 h of incubation at 0°C, the lysate was clarified by centrifugation at 45,000 x g for 1 h.
[35S]methionine labeling. lH10 cells restimulated 1 week earlier and P815 cells were washed three times in medium followed by one wash in methionine-free minimum essential medium (GIBCO cyl sulfate, 0.125 M Tris (pH 6.8), and 10% ,-mercaptoethanol and boiled for 3 min. Solubilized samples were separated on 10% polyacrylamide gels by sodium dodecyl sulfate-polyacylamide gel electrophoresis by the method of Laemmli (9) . Gels were stained by using Coomassie brilliant blue, destained in 7.5% methanol-5% acetic acid, washed in water, dried, and exposed to Kodak XAR-5 film.
[35S] methionine-labeled sample gels were incubated with Autofluor (National Diagnostics) before they were dried. The experiment was also performed by using a murine antiglycoprotein G monoclonal antibody. RESULTS lH10 is a VSV-specific T clone. The VSV-antigen-specific T-cell clone, lH10, was derived after limiting dilution from bulk cultures of VSV-challenged spleen cells from BALB/c mice immunized with VSV. It was found to be responsive only to UV-VSV, not to HSV or reovirus, as shown by its enhanced proliferative response to VSV but not to HSV or reovirus, indicating the exquisite specificity of the clone for VSV (Fig. 1 ). An HSV-specific CD4+ CD8-T-cell clone from A/J mice was obtained in a similar manner. This clone proliferates in response to UV-HSV, not to UV-VSV (data not shown). The lH10 clone was found to be positive for L3T4 (murine CD4) (4, 5), Lyt-1 (10), 145-2C11 (e chain of murine CD3) (11), and F23.1 (protein encoded by the V,8 region of the murine T-cell receptor) (26) but negative for Lyt-2 (murine CD8) (10) . The supernatants of the lH10 T-cell clones were found to contain infectious virus 1 week after the last stimulation when cocultured with L cells. Gamma interferon was not detected in the supernatant.
Antibody directed against CD4 inhibits the proliferative response of 1H10. In order to determine the role played by CD4 in VSV-induced proliferation of the lH10 clone, we added antibody to L3T4, the murine CD4 (GK1.5), and Lyt-2, the murine CD8 (53-6.72), with a medium alone as a control. Proliferation was inhibited by antibody to CD4 (GK1.5) but not by anti-CD8 antibody (53-6.72) (data not shown).
The lH10 clone kills target cells bearing class II MHC antigens. Cytolytic activity of IH10 was tested at ratios ranging from 12.5:1 to 1:1. The clone was found to be capable of lysing target cells at a 6:1 ratio of effector cells to target cells in a 6-h cytolytic assay with a greater than 60% 51Cr release. The targets were chosen on the basis of the differences in expression of class I and class II MHC antigens in order to delineate the MHC restriction of the clone. The target used in Fig. 2a was A20, a histocompatible (H-2d) BALB/c lymphoma cell line expressing both class I and class II MHC antigens. The killing was VSV specific; no HSV-or reovirus-infected target cells were killed during the assay (Fig. 2a) . The clone was incapable of significant killing of VSV-infected P815 cells (H-2d+ Iad-) (Fig. 2b ) in a 6-h assay. Furthermore, the antibody M5/114.15.2 (1), which can bind to IAd and IEd MHC antigens, blocked the killing of A20 cells (Fig. 2c) (Fig. 3a) . Because of the absence of target cell specificity, we postulated that lH10 might be releasing lymphotoxin or other toxic lymphokines. However, assays in the presence of anti-VSV sera revealed a loss of this effect, suggesting the presence of virus-induced cytolysis (Fig. 3b) . Sera from unimmunized mice had no effect on the inhibition of tumor proliferation by the T-cell clone. Similar results were obtained when rabbit anti-VSV sera (Lee BioMolecular) were used instead of mouse anti-VSV sera. In a 48-h assay in the presence of both UV-VSV and antiserum against VSV, irradiated lH10 cells were also found to be capable of a greater than 95% inhibition of proliferation of A20 cells (MHC-compatible cells expressing class II antigens) but not of P815, AJ9, or BW5147 target cells (data not shown).
The lH10 clone cured of virus does not mediate nonspecific lysis. In order to determine whether the lytic effect against nonhistocompatible target cells was mediated by virus, IH10 cells were carried in the presence of serum from syngeneic mice immunized with VSV. After passage of cells in antiserum, the clone behaved like a prototypic virus-specific class II-directed CD4 cell (Fig. 4) was stained with anti-CD4 (GK1.5) and anti-VSV serum separately and was found to have a single peak for each of these two antibodies. Over 30% of these cells stained with antibodies to both L3T4 and VSV, indicating the persistence of viral antigen on the surfaces of these cells (Fig. 5) tivated with lH10 but not from lH10 or P815 alone (results not shown).
DISCUSSION
In this report, we have described a T-cell clone with a CD4+ CD8-phenotype which is specific for VSV. The clone proliferates in response to antigen and exhibits class IIrestricted cytolysis, as demonstrated by its ability to kill VSV-infected syngeneic cells which express class II MHC antigens but not cells which express class I MHC antigens alone. Interestingly, these cells are capable not only of mediating the functional activities described above but also of carrying live VSV on their surfaces, as shown by FACS staining and surface iodination and immunoprecipitation experiments. These cells by themselves are not rapidly clone evades cytolysis by VSV remains uncertain. Experiments with cloned alloreactive T cells and T-cell lines specific against reovirus and Sendai virus indicate that these cells are killed when VSV is added to cultures (unpublished data), confirming the findings of Kano et al. (8) . It is possible that the virus is unable to enter the VSV-specific T cell because of an endogenous defense mechanism such as interferon. Murine interferon has been found to inhibit the penetration of VSV into L cells without affecting the adsorption of the virus (30) . The role of possible defective interfering viral particles in the induction of interferon production in T cells is uncertain, although there is evidence that it occurs in persistently infected L cells (15) . It is clear that the failure of the virus to kill the T-cell clone is not due to inability of the clone to bind virus (Fig. 5) . Others have noted that certain tumor cells may be persistently infected with low levels of virus without detectable proviral nucleic acid and that such cells could be cured of VSV (7) .
In these experiments, we have found that most of our cloned T cells expressed viral antigen on (20) . However, they did not assess viability or functional activities of these cells after challenge with VSV. None of these investigators have addressed the paradox of how, if the virus kills and activates T cells, the host can generate a virusspecific response. In addressing this question, we described a clone that not only resists viral infection but also carries the virus in a functionally important manner, i.e., is able to spread the virus to other cells and kill them.
It is unlikely that the T cells obtained in this work mediate target cell lysis by secretion of any toxic agents (e.g., lymphotoxin, perforin, serine esterase, etc.) because the non-MHC-restricted tumor lysis by the lH10 clone is inhibited if the clone is either cured of the VSV several days before coculturing with the tumor target cells or added to tumor target cells simultaneously with the anti-VSV sera. This has been verified by the observation that plaques may be formed on L-cell (H-2k) layers by infected T-cell clone cells in an infectious center assay (unpublished data).
Our clone is unique in that it mediates lysis of target cells by carrying virus on the surface but is not itself lysed by the virus. Lysis of the tumor target cell is clearly mediated by infectious virus, as was demonstrated in the [35S]methionine cocultivation experiments (Fig. 7) , where P815 expressed VSV antigens when cocultured with the lH10 clone. It is intriguing to speculate that such Trojan horse lymphocytes may be involved in the pathogenesis of viral infections by harboring viruses and then spreading the infection to susceptible tissue before neutralizing antibodies could be produced. In vivo experiments by Oldstone and colleagues have defined the association of infectious lymphocytic choriomeningitis virus particles with T cells (17) . The implications of these findings in terms of disease pathogenesis have not yet been established.
Cytolytic T cells are known to be serial killers capable of killing multiple target cells. Cinematic studies of such cells reveal that they wander from one cell to the next, bypassing target cells not recognized by their T-cell receptor prior to giving the lethal hit to an antigen and MHC-compatible cell (19) . This wandering from one cell to another requires cell-to-cell contact. In this case, the cell-to-cell contact results in the lysis of any cell which the lH10 cell contacts. While viruses, unlike bacteria, usually cannot survive extracellularly in the blood for extended periods, they may be able to hitchhike around the body by taking advantage of the circulating cells. Cytolytic T lymphocytes are ideal for this purpose since they travel around the body contacting one cell after another. In the case of an infected lymphocyte, the phenomenon of cell-to-cell contact may result in the lysis of the target cell by a hitherto unreported mechanism: release of live virus from the cell membrane. Such a mechanism may be operative in certain viral or even so-called autoimmune effects which follow viral infections. 
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